M3’s profile rising further
In a spree of positive updates to start 2022, Destiny Pharma begins the year with the profile of...
Read moreTime to buy the dip
Eleco is an IRP-rich firm that is trading at an unjustified discount to peers (2.4x fwd EV/sales vs...
Read moreReasons for optimism
Despite the delay, the results for the year to September were in-line with expectations at the adj....
Read moreWell positioned for strong sales growth in FY2022
ASC announced around 20% sales growth in a FY2021 trading update released today. Sales growth was...
Read moreEarly strategic progress not reflected in valuation
H1 ‘22 results (to 30 Nov ‘21) show steady progress on key metrics, with signs that Time’s refined...
Read moreFY’22 NFI set to climb 7% as investment kicks in
Due to the latest Omicron outbreak, the pace of economic recovery has temporarily hit a soft patch....
Read moreEstablished leader in detection solutions
Kromek delivered a sound, well-managed, H1 performance given industry-wide supply chain and...
Read moreOn track to meet full-year AUM forecast
AUM reached £24.3bn on 31 Dec 21, nine months into the financial year, up £3.4bn or 17% over the...
Read moreTrading update confirms a strong FY21
In a Trading Update for the year ended December 31st 2021 Mpac Group confirms strong performance...
Read moreQ1 AUM ahead of forecast
AUM grew by £4.1bn over Q1 of FY22 (1 Oct 21 – 30 Sep 22), reaching £41.4bn on 31 Dec 21, 11% up...
Read moreBolt-on adds scale and profile to property services
BEG’s latest acquisition, chartered surveying firm Daniells Harrison, extends its geographical...
Read moreFinancials reflect increased investment
RUA Life Sciences interim results demonstrated the continued investment in the business and its new...
Read more- Prev
- 1 of 57 pages
- Next
Register to be first
Get research on the companies that interest you straight to your inbox
